Not applicableStudy completedNCT05678517What this trial is testingSeven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMDWho this might be right forAge-Related Macular Degeneration Semmelweis University 47
Large-scale testing (Phase 3)WithdrawnNCT04465734What this trial is testingA Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCCWho this might be right forHepatocellular Carcinoma (HCC) Shanghai Henlius Biotech
Large-scale testing (Phase 3)Study completedNCT00601900What this trial is testingTamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast CancerWho this might be right forInvasive Breast CarcinomaRecurrent Breast CarcinomaStage III Breast Cancer AJCC v6+1 more National Cancer Institute (NCI) 394
Not applicableStudy completedNCT00804934What this trial is testingInvestigates Improvement in Vision Following Switching From Avastin and Macugen Over to LucentisWho this might be right forWet AMD Retina Institute of Hawaii 100
Early research (Phase 1)Study completedNCT03748784What this trial is testingADVM-022 Intravitreal Gene Therapy for Wet AMDWho this might be right forWet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 30
Large-scale testing (Phase 3)UnknownNCT03452657What this trial is testingMulticenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)Who this might be right forDiabetic RetinopathyRanibizumab Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 118
Post-approval studies (Phase 4)Study completedNCT01027481What this trial is testingRanibizumab in Patients With Branch Retinal Vein OcclusionWho this might be right forRetinal Vein Occlusion Medical University of Vienna 30
Early research (Phase 1)Looking for participantsNCT06307249What this trial is testingPrecision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNAWho this might be right forCancerSolid TumorColorectal Cancer+7 more Lebanese University 50
Not applicableStudy completedNCT01846351What this trial is testingIntravitreal Anti-VEGF in Exudative AMD With Epiretinal MembranesWho this might be right forEpiretinal MembraneAge Related Macular Degeneration New England Retina Associates 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05984927What this trial is testingNG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Elisigen, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02397954What this trial is testingEstablish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)Who this might be right forIdiopathic Polypoidal Choroidal Vasculopathy Ophthotech Corporation 4
Post-approval studies (Phase 4)Study completedNCT01006538What this trial is testingMacular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)Who this might be right forMacular Degeneration King's College Hospital NHS Trust 363
Not applicableUnknownNCT04245072What this trial is testingAntiangiogenic Therapy of Choroidal Neovascularisation Associated With Central ChorioretinitisWho this might be right forChorioretinitis The Filatov Institute of Eye Diseases and Tissue Therapy 100
Early research (Phase 1)Active Not RecruitingNCT04844619What this trial is testingKDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) TrialWho this might be right forNeovascular GlaucomaNeovascularization Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT04736810What this trial is testingPenpulimab Combination Therapy in Patients With Advanced Nasopharyngeal CarcinomaWho this might be right forNasopharyngeal Carcinoma Akeso 28
Post-approval studies (Phase 4)Study completedNCT01495221What this trial is testingTo Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMDWho this might be right forAMD (With Persistent or Recurrent Fluid Despite Monthly Intravitreal Anti-VEGF Therapy) Vitreous -Retina- Macula Consultants of New York 9
Not applicableNot Yet RecruitingNCT06817915What this trial is testingThis Project At LMU Looks At How Using AI 2nd Opinion Report to Analyze Retinal Eye Scans Impact Doctors' Decisions About Treatment for Patients with a Specific Eye Disease (nAMD)Who this might be right forNeovascular Age-Related Macular Degeneration (nAMD) Johannes Schiefelbein 100
Not applicableLooking for participantsNCT06610747What this trial is testingHome- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCTWho this might be right forDiabetic Macular Edema Zhongshan Ophthalmic Center, Sun Yat-sen University 308
Large-scale testing (Phase 3)Looking for participantsNCT06985706What this trial is testingAnti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 MicronsWho this might be right forSevere Diabetic Macular Oedema Belfast Health and Social Care Trust 264
Not applicableStudy completedNCT02956330What this trial is testingRetrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201Who this might be right forMacular EdemaRetinal Vein Occlusion Clearside Biomedical, Inc. 20